T. Rowe Price Associates
NEUE

T. Rowe Price Associates’s NeueHealth NEUE Stock Holding History

T. Rowe Price Associates’s Portfolio NEUE Stock Details NEUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-457
Closed -$9K – 2956
2023
Q1 		$9K Sell
457
-2,196
-83% -$113K ﹤0.01% 2884
2022
Q4 		$138K Buy
2,653
+12
+0.5% +$872 ﹤0.01% 2643
2022
Q3 		$223K Buy
2,641
+148
+6% +$19.6K ﹤0.01% 2506
2022
Q2 		$363K Sell
2,493
-61
-2% -$8.88K ﹤0.01% 2363
2022
Q1 		$394K Buy
2,554
+16
+0.6% +$3.55K ﹤0.01% 2445
2021
Q4 		$698K Sell
2,538
-264,127
-99% -$122M ﹤0.01% 2223
2021
Q3 		$171M Buy
266,665
+4,652
+2% +$4.09M 0.02% 596
2021
Q2 		$353M Buy
+262,013
New +$359M 0.03% 417

Other funds holding NEUE

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
RM
Redpoint Management Woodside, California $201M AUM 39.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
G
Greycroft New York $146M AUM 1.94% 1-Year Est. Return
MCAV
Meritech Capital Associates VI Palo Alto, California $45.3M AUM 4.6% 1-Year Est. Return
PGH
Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates's NEUE Position: Q2 2023 in Review

T. Rowe Price Associates sold out of NeueHealth (NEUE) in Q2 2023, closing a stake of 457 shares — an estimated $9K sold.

T. Rowe Price Associates first reported a position in NEUE in Q2 2021 and held it in 8 quarters. The position peaked at $353M in Q2 2021. 49 funds tracked by Wall St. Rank hold NEUE as of Q2 2023.

  • T. Rowe Price Associates reported no remaining NeueHealth position as of Q2 2023 after selling out during the quarter.
  • T. Rowe Price Associates sold 457 NeueHealth shares in Q2 2023, an estimated $9K.
  • T. Rowe Price Associates first reported a position in NeueHealth in Q2 2021 and held it in 8 quarters.
  • T. Rowe Price Associates's NeueHealth position peaked at $353M in Q2 2021.
  • 49 funds tracked by Wall St. Rank held NeueHealth as of Q2 2023.

Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.